US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CNBX Pharmaceuticals Inc.

0.0001

0.0000

Volume:- -

Turnover:- -

Market Cap:87.08K

PE:-0.07

High:0.0001

Open:0.0001

Low:0.0001

Close:0.0001

52wk High:0.0113

52wk Low:0.0001

Shares:870.77M

Float Shares:91.79M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0015

EPS(LYR):-0.0035

ROE:-4289.36%

ROA:-1116.13%

PB:-0.03

PE(LYR):-0.03

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CNBX Pharmaceuticals Inc.

Exchange:

PINK LIMITED

Establishment Date:

2004

Employees:

1

Office Location:

#3 Bethesda Metro Center,Suite 700,Bethesda,Maryland,United States

Website:

http://www.cannabics.com

Zip Code:

20814

Phone:

Fax:

- -

Introduction:

CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNBX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CNBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNBX\",,,,,undefined,":{"symbol":"CNBX","market":"US","secType":"STK","nameCN":"CNBX Pharmaceuticals Inc.","latestPrice":0.0001,"timestamp":1774382400000,"preClose":0.0001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":91785600,"shares":870768095,"eps":-0.00149,"marketStatus":"Post-Mkt","change":0,"latestTime":"03-24 16:00:00 EDT Delay","open":0.0001,"high":0.0001,"low":0.0001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.00149,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774396800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":0.0001,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNBX\",,,,,undefined,":{"symbol":"CNBX","floatShares":91785600,"roa":"-1116.13%","roe":"-4289.36%","lyrEps":-0.003463,"shares":870768095,"dividePrice":0,"high":0.0001,"amplitude":0,"preClose":0.0001,"low":0.0001,"week52Low":0.0001,"pbRate":"-0.03","week52High":0.0113,"institutionHeld":0,"latestPrice":0.0001,"eps":-0.00149,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.00149,"open":0.0001,"prevYearClose":0.0004,"prevWeekClose":0.0001,"prevMonthClose":0.0001,"prevQuarterClose":0.0004,"fiveDayClose":0.0001,"twentyDayClose":0.0001,"sixtyDayClose":0.0004},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-07-15","symbol":"CNBX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1721016000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-01-12","symbol":"CNBX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1705035600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-29","symbol":"CNBX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1701234000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-05-12","symbol":"CNBX","defaultRemindTime":1652362200000,"type":"split","dateTimestamp":1652328000000,"forFactor":1000000,"toFactor":8333,"ratio":120.00480019200768}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNBX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":130738072,"yearFounded":2004,"employeeNum":1,"address":"#3 Bethesda Metro Center,Suite 700,Bethesda,Maryland,United States","zipCode":"20814","officePhone":"877 424 2429"},"stockCompanyDetail":{"websiteUrl":"http://www.cannabics.com","stockEarnings":[{"period":"1week","weight":0.1398},{"period":"1month","weight":0.0778},{"period":"3month","weight":-0.21},{"period":"6month","weight":-0.2942},{"period":"1year","weight":-0.6515},{"period":"ytd","weight":-0.1828}],"description":"CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland.","exchange":"PINK LIMITED","name":"CNBX Pharmaceuticals Inc.","nameEN":"CNBX Pharmaceuticals Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CNBX\",market:\"US\",,,undefined,":null}}